@article{58887e4e5e8440efba6c32263ec49c3e,
title = "Sulfasalazine: a risk factor for severe COVID-19?",
author = "Konig, {Maximilian F.} and Grzes, {Katarzyna M.} and Robinson, {Philip C.} and Pearce, {Edward J.}",
note = "Funding Information: MFK was supported by Jerome L Greene Foundation Scholar and Discovery Awards and the Peter and Carmen Lucia Buck Foundation Myositis Discovery Fund. EJP is a founder and advisor of Rheos Medicines. KMG and EJP have filed, in Germany, a provisional application for an international patent titled “Combined inhibition of amino acid transporters for inhibiting human plasmacytoid dendritic cell activity during autoimmunity” (PCT/EP2021/084428). All other authors declare no competing interests.",
year = "2022",
month = jun,
doi = "10.1016/S2665-9913(22)00067-4",
language = "English (US)",
volume = "4",
pages = "e388--e389",
journal = "The Lancet Rheumatology",
issn = "2665-9913",
publisher = "Elsevier Ltd",
number = "6",
}